BRAFV600E mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation. (Q53265606)

12 May 2018

title

BRAFV600E mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation. (English)

1 reference

12 May 2018

1 reference

Renu K Virk

1

1 reference

12 May 2018

Alison L Van Dyke

2

1 reference

12 May 2018

Alexander Finkelstein

3

1 reference

12 May 2018

Avinash Prasad

4

1 reference

12 May 2018

Joanna Gibson

5

1 reference

12 May 2018

Pei Hui

6

1 reference

12 May 2018

Constantine G Theoharis

7

1 reference

12 May 2018

Tobias Carling

8

1 reference

12 May 2018

Sanziana A Roman

9

1 reference

12 May 2018

Julie A Sosa

10

1 reference

12 May 2018

Robert Udelsman

11

1 reference

12 May 2018

Manju L Prasad

12

1 reference

12 May 2018

publication date

24 August 2012

1 reference

12 May 2018

published in

Modern Pathology

1 reference

12 May 2018

volume

26

1 reference

12 May 2018

issue

1

1 reference

12 May 2018

page(s)

62-70

1 reference

12 May 2018

https://scigraph.springernature.com/pub.10.1038/modpathol.2012.152

exact match

0 references

cites work

Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.152

Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.152

BRAF mutation in papillary thyroid microcarcinoma: the promise of better risk management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.152

'Aggressive papillary' thyroid microcarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.152

Incidental papillary microcarcinoma of the thyroid--further evidence of a very low malignant potential: a retrospective clinicopathological study with up to 30 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.152

Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.152

Analysis of differential BRAF(V600E) mutational status in high aggressive papillary thyroid microcarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.152

Association of BRAFV600E mutation with poor clinical prognostic factors and US features in Korean patients with papillary thyroid microcarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.152

The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.152

Papillary thyroid carcinomas with and without BRAF V600E mutations are morphologically distinct.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.152

Papillary thyroid carcinoma tall cell variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.152

The National Cancer Institute Thyroid fine needle aspiration state of the science conference: a summation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.152

Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.152

Differential effects between cyclooxygenase-2 inhibitors and siRNA on vascular endothelial growth factor production in head and neck squamous cell carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.152

BRAF mutation testing in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.152

Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.152

Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.152

Extrathyroid extension of well-differentiated papillary thyroid microcarcinoma on US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.152

Desmoplastic stromal reaction in papillary thyroid microcarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.152

Conditional activation of RET/PTC3 and BRAFV600E in thyroid cells is associated with gene expression profiles that predict a preferential role of BRAF in extracellular matrix remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.152

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.152

Molecular, morphologic, and outcome analysis of thyroid carcinomas according to degree of extrathyroid extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.152

A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.152

Increasing incidence of thyroid cancer in the United States, 1973-2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.152

7 January 2021

The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.152

7 January 2021

BRAF Mutation in Papillary Thyroid Carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.152

7 January 2021

Presence of BRAF V600E in very early stages of papillary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.152

7 January 2021

Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.152

7 January 2021

10.1038/MODPATHOL.2012.152

Identifiers

DOI

1 reference

12 May 2018

PubMed ID

22918165

1 reference

12 May 2018